Summary
The global Celiac Disease Drug Market is expected to witness a CAGR of xx% over the forecast period 2020-2026 and is expected to reach US$ xx million in 2026, from US$ xx million in 2019.
Celiac disease is a chronic digestive disorder resulting from an immune reaction to gliadin, a gluten protein found in wheat, barley, rye, and sometimes oats.
Increasing number of clinical trials for celiac disease treatment is expected to propel growth of the global celiac disease drugs market over the forecast period. For instance, in September 2020, Beyond Celiac, a leading catalyst for a celiac disease cure in the United States, partnered with Provention Bio, Inc. to provide clinical trial recruitment for the biopharmaceutical company’s Phase 2b PROACTIVE (PROvention Amgen Celiac ProtecTIVE) study of PRV-015 (an anti-interleukin-15 monoclonal antibody) for the treatment of celiac disease.
R&D in celiac disease is expected to offer lucrative growth opportunities for players in the global celiac disease drugs market over the forecast period. For instance, in October 2020, a team of researchers from McMaster University—in partnership with the Canadian Celiac Association (CCA), announced a research to determine if people with celiac disease were at an increased risk of contracting COVID-19. Moreover, initiatives to boost diagnosis and treatment of celiac disease is also expected to aid in growth of the market. For instance, in October 2020, Beyond Celiac, a leading patient organization and catalyst for a celiac disease cure in the U.S. partnered with National Minority Quality Forum (NMQF), a research and educational organization, to examine and address health inequities in the diagnosis and treatment of celiac disease.
However, high healthcare costs for celiac disease patients is expected to hinder growth of the global celiac disease drugs market over the forecast period. For instance, according to a study published in the American Journal of Gastroenterology, in September 2020, researchers from IBM Watson Health, Takeda Pharmaceuticals, and Beth Israel Deaconess Medical Center found that in the year prior to diagnosis, those with celiac disease paid an average of about US$ 4,000 more in all healthcare costs than controls. In the first year of follow-up, celiac disease patients paid an average of about US$ 8,000 more than controls and in the second year, about US$ 4,000 more.
Key Takeaways
- Increasing number of clinical trials for celiac disease treatment is expected to propel growth of the global celiac disease drugs market over the forecast period
- Major players operating in the global celiac disease drugs market are focused on R&D of new products to expand their product portfolio. For instance, in August 2020, Provention Bio, Inc. initiated the Phase 2b PROACTIVE study of PRV-015, an anti-interleukin-15 monoclonal antibody, in adult celiac patients not responding to a gluten-free diet, a condition known as 'Non-Responsive Celiac Disease'.
- Major players operating in the global celiac disease drugs market include, F. Hoffmann-La Roche, Johnson & Johnson, Merck, Pfizer, Inc., ADMA Biologics, Amgen, Anthera Pharmaceuticals, Bayer International, Biogen, BioLineRx, Biotest, Bristol-Myers Squibb, Celgene, Takeda Pharmaceutical, Novartis AG, Provention Bio, Inc., and LFB Group.
The Celiac Disease Drug Market report highlights product development and growth strategies such as merger and acquisition adopted by market players along with SWOT Analysis, PEST and Porter’s Five Forces analyses of the Celiac Disease Drug Market, which highlight the strengths, weaknesses, opportunities, and commination of key companies. Moreover, the report offers two distinct market forecasts, one from the perspective of the producer and another from that of the consumer.
The various contributors involved in the value chain of the product include manufacturers, suppliers, distributors, intermediaries, and customers.
The Key Manufacturers covered in this Report:-
- F. Hoffmann-La Roche
- Johnson & Johnson
- Merck
- Pfizer
- ADMA Biologics
- Amgen
- Anthera Pharmaceuticals
- Bayer
- Biogen
- BioLineRx
- Biotest
- Bristol-Myers Squibb
- Celgene
- Takeda Pharmaceutical
- Novartis
- LFB Group
- Kedrion Biopharma
By the Product Type, the market is primarily segmented into:
- Distension
- Diarrhea
- Anorexia
- Others
By Applications, the market is segmented into:
- First line of treatment
- Second line of treatment
The Report covers the following Regions:
- North America
- United States
- Canada
- Mexico
- Asia Pacific
- China
- Japan
- South Korea
- India
- Australia
- Indonesia
- Thailand
- Malaysia
- Philippines
- Vietnam
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Central & South America
- Middle East & Africa
- Turkey
- GCC Countries
- Egypt
- South Africa
Objective of the Celiac Disease Drug Market Report:
- To assess the size of the market by value and volume
- Analyze the Celiac Disease Drug Market in terms of regions and major countries
- Highlight recent developments and trends in the market
- Offer perceptive data regarding major market players in terms of key developments, strategies, and product portfolio
- Determine share of the Celiac Disease Drug Market in terms of various segments such as by product type, application, and end-user
- Offer accurate projection of the market for the forecast period using state-of –the-art tools and the current primary and secondary research approaches
- Discuss major factors that impact growth of the Celiac Disease Drug Market
The Celiac Disease Drug Market engages the readers with all pivotal approaches to understand their position in the industry based on revenue or sales growth. The report efficiently evaluates the Celiac Disease Drug Market from various dimensions to deliver an end-product that is informative, elaborate, and accurate and includes detailed market segmentation, regional analysis, and competition in the market. The information in the report is backed by annual company reports, financial reports, press releases, regulatory databases, government documents, and statistical databases.
For the data information by region, company, type and application, 2019 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Key Stakeholders:
- Material suppliers/wholesalers
- Market Distributors/traders
- Regulatory bodies
- Research organizations, and consulting firms
- Commercial research & developments (R&D)
- Trade associations and industry bodies
- Importers and exporters
- End-use industries
Available Customizations:
Custom research is one of the most crucial components of the business strategy that helps an organization gain insight into specific business sector, aligned with its specific area of interest. Thus, SMI offers more accurate, pragmatic, and actionable information specifically tailored to suit your business needs.
Table of Contents
Executive Summary
1 Industry Overview of Celiac Disease Drug
1.1 Definition of Celiac Disease Drug
1.2 Celiac Disease Drug Segment by Type
1.2.1 Global Celiac Disease Drug Production Growth Rate Comparison by Types (2014-2025)
1.2.2 Distension
1.2.3 Diarrhea
1.2.4 Anorexia
1.2.5 Others
1.3 Celiac Disease Drug Segment by Applications
1.3.1 Global Celiac Disease Drug Consumption Comparison by Applications (2014-2025)
1.3.2 First line of treatment
1.3.3 Second line of treatment
1.4 Global Celiac Disease Drug Overall Market
1.4.1 Global Celiac Disease Drug Revenue (2014-2025)
1.4.2 Global Celiac Disease Drug Production (2014-2025)
1.4.3 North America Celiac Disease Drug Status and Prospect (2014-2025)
1.4.4 Europe Celiac Disease Drug Status and Prospect (2014-2025)
1.4.5 China Celiac Disease Drug Status and Prospect (2014-2025)
1.4.6 Japan Celiac Disease Drug Status and Prospect (2014-2025)
1.4.7 Southeast Asia Celiac Disease Drug Status and Prospect (2014-2025)
1.4.8 India Celiac Disease Drug Status and Prospect (2014-2025)
2 Manufacturing Cost Structure Analysis
2.1 Raw Material and Suppliers
2.2 Manufacturing Cost Structure Analysis of Celiac Disease Drug
2.3 Manufacturing Process Analysis of Celiac Disease Drug
2.4 Industry Chain Structure of Celiac Disease Drug
3 Development and Manufacturing Plants Analysis of Celiac Disease Drug
3.1 Capacity and Commercial Production Date
3.2 Global Celiac Disease Drug Manufacturing Plants Distribution
3.3 Major Manufacturers Technology Source and Market Position of Celiac Disease Drug
3.4 Recent Development and Expansion Plans
4 Key Figures of Major Manufacturers
4.1 Celiac Disease Drug Production and Capacity Analysis
4.2 Celiac Disease Drug Revenue Analysis
4.3 Celiac Disease Drug Price Analysis
4.4 Market Concentration Degree
5 Celiac Disease Drug Regional Market Analysis
5.1 Celiac Disease Drug Production by Regions
5.1.1 Global Celiac Disease Drug Production by Regions
5.1.2 Global Celiac Disease Drug Revenue by Regions
5.2 Celiac Disease Drug Consumption by Regions
5.3 North America Celiac Disease Drug Market Analysis
5.3.1 North America Celiac Disease Drug Production
5.3.2 North America Celiac Disease Drug Revenue
5.3.3 Key Manufacturers in North America
5.3.4 North America Celiac Disease Drug Import and Export
5.4 Europe Celiac Disease Drug Market Analysis
5.4.1 Europe Celiac Disease Drug Production
5.4.2 Europe Celiac Disease Drug Revenue
5.4.3 Key Manufacturers in Europe
5.4.4 Europe Celiac Disease Drug Import and Export
5.5 China Celiac Disease Drug Market Analysis
5.5.1 China Celiac Disease Drug Production
5.5.2 China Celiac Disease Drug Revenue
5.5.3 Key Manufacturers in China
5.5.4 China Celiac Disease Drug Import and Export
5.6 Japan Celiac Disease Drug Market Analysis
5.6.1 Japan Celiac Disease Drug Production
5.6.2 Japan Celiac Disease Drug Revenue
5.6.3 Key Manufacturers in Japan
5.6.4 Japan Celiac Disease Drug Import and Export
5.7 Southeast Asia Celiac Disease Drug Market Analysis
5.7.1 Southeast Asia Celiac Disease Drug Production
5.7.2 Southeast Asia Celiac Disease Drug Revenue
5.7.3 Key Manufacturers in Southeast Asia
5.7.4 Southeast Asia Celiac Disease Drug Import and Export
5.8 India Celiac Disease Drug Market Analysis
5.8.1 India Celiac Disease Drug Production
5.8.2 India Celiac Disease Drug Revenue
5.8.3 Key Manufacturers in India
5.8.4 India Celiac Disease Drug Import and Export
6 Celiac Disease Drug Segment Market Analysis (by Type)
6.1 Global Celiac Disease Drug Production by Type
6.2 Global Celiac Disease Drug Revenue by Type
6.3 Celiac Disease Drug Price by Type
7 Celiac Disease Drug Segment Market Analysis (by Application)
7.1 Global Celiac Disease Drug Consumption by Application
7.2 Global Celiac Disease Drug Consumption Market Share by Application (2014-2019)
8 Celiac Disease Drug Major Manufacturers Analysis
8.1 F. Hoffmann-La Roche
8.1.1 F. Hoffmann-La Roche Celiac Disease Drug Production Sites and Area Served
8.1.2 F. Hoffmann-La Roche Product Introduction, Application and Specification
8.1.3 F. Hoffmann-La Roche Celiac Disease Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.1.4 Main Business and Markets Served
8.2 Johnson & Johnson
8.2.1 Johnson & Johnson Celiac Disease Drug Production Sites and Area Served
8.2.2 Johnson & Johnson Product Introduction, Application and Specification
8.2.3 Johnson & Johnson Celiac Disease Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.2.4 Main Business and Markets Served
8.3 Merck
8.3.1 Merck Celiac Disease Drug Production Sites and Area Served
8.3.2 Merck Product Introduction, Application and Specification
8.3.3 Merck Celiac Disease Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.3.4 Main Business and Markets Served
8.4 Pfizer
8.4.1 Pfizer Celiac Disease Drug Production Sites and Area Served
8.4.2 Pfizer Product Introduction, Application and Specification
8.4.3 Pfizer Celiac Disease Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.4.4 Main Business and Markets Served
8.5 ADMA Biologics
8.5.1 ADMA Biologics Celiac Disease Drug Production Sites and Area Served
8.5.2 ADMA Biologics Product Introduction, Application and Specification
8.5.3 ADMA Biologics Celiac Disease Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.5.4 Main Business and Markets Served
8.6 Amgen
8.6.1 Amgen Celiac Disease Drug Production Sites and Area Served
8.6.2 Amgen Product Introduction, Application and Specification
8.6.3 Amgen Celiac Disease Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.6.4 Main Business and Markets Served
8.7 Anthera Pharmaceuticals
8.7.1 Anthera Pharmaceuticals Celiac Disease Drug Production Sites and Area Served
8.7.2 Anthera Pharmaceuticals Product Introduction, Application and Specification
8.7.3 Anthera Pharmaceuticals Celiac Disease Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.7.4 Main Business and Markets Served
8.8 Bayer
8.8.1 Bayer Celiac Disease Drug Production Sites and Area Served
8.8.2 Bayer Product Introduction, Application and Specification
8.8.3 Bayer Celiac Disease Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.8.4 Main Business and Markets Served
8.9 Biogen
8.9.1 Biogen Celiac Disease Drug Production Sites and Area Served
8.9.2 Biogen Product Introduction, Application and Specification
8.9.3 Biogen Celiac Disease Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.9.4 Main Business and Markets Served
8.10 BioLineRx
8.10.1 BioLineRx Celiac Disease Drug Production Sites and Area Served
8.10.2 BioLineRx Product Introduction, Application and Specification
8.10.3 BioLineRx Celiac Disease Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.10.4 Main Business and Markets Served
8.11 Biotest
8.12 Bristol-Myers Squibb
8.13 Celgene
8.14 Takeda Pharmaceutical
8.15 Novartis
8.16 LFB Group
8.17 Kedrion Biopharma
9 Development Trend of Analysis of Celiac Disease Drug Market
9.1 Global Celiac Disease Drug Market Trend Analysis
9.1.1 Global Celiac Disease Drug Market Size (Volume and Value) Forecast 2019-2025
9.2 Celiac Disease Drug Regional Market Trend
9.2.1 North America Celiac Disease Drug Forecast 2019-2025
9.2.2 Europe Celiac Disease Drug Forecast 2019-2025
9.2.3 China Celiac Disease Drug Forecast 2019-2025
9.2.4 Japan Celiac Disease Drug Forecast 2019-2025
9.2.5 Southeast Asia Celiac Disease Drug Forecast 2019-2025
9.2.6 India Celiac Disease Drug Forecast 2019-2025
9.3 Celiac Disease Drug Market Trend (Product Type)
9.4 Celiac Disease Drug Market Trend (Application)
10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.3 Celiac Disease Drug Customers
11 Market Dynamics
11.1 Market Trends
11.2 Opportunities
11.3 Market Drivers
11.4 Challenges
11.5 Influence Factors
12 Conclusion
13 Appendix
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Author List
13.4 Disclaimer
List of Table
List of Tables and Figures
Figure Picture of Celiac Disease Drug
Table Global Celiac Disease Drug Production (K Pcs) Growth Rate Comparison by Types (2014-2025)
Figure Global Celiac Disease Drug Production Market Share by Types in 2018
Figure Distension Product Picture
Figure Diarrhea Product Picture
Figure Anorexia Product Picture
Figure Others Product Picture
Table Global Celiac Disease Drug Consumption (K Pcs) Comparison by Applications (2014-2025)
Figure Global Celiac Disease Drug Consumption Market Share by Applications in 2018
Figure First line of treatment
Figure Second line of treatment
Figure Global Celiac Disease Drug Revenue (Million USD) (2014-2025)
Figure Global Celiac Disease Drug Production (K Pcs) (2014-2025)
Figure North America Celiac Disease Drug Market Size (Million USD) (2014-2025)
Figure Europe Celiac Disease Drug Market Size (Million USD) (2014-2025)
Figure China Celiac Disease Drug Market Size (Million USD) (2014-2025)
Figure Japan Celiac Disease Drug Market Size (Million USD) (2014-2025)
Figure Southeast Asia Celiac Disease Drug Market Size (Million USD) (2014-2025)
Figure India Celiac Disease Drug Market Size (Million USD) (2014-2025)
Table Celiac Disease Drug Raw Material and Suppliers
Table Manufacturing Cost Structure Analysis of Celiac Disease Drug in 2018
Figure Manufacturing Process Analysis of Celiac Disease Drug
Figure Industry Chain Structure of Celiac Disease Drug
Table Capacity and Commercial Production Date of Key Manufacturers
Table Global Celiac Disease Drug Manufacturing Plants Distribution
Table Celiac Disease Drug Major Manufacturers Technology Source and Market Position
Table Recent Development and Expansion Plans in Future
Table Celiac Disease Drug Capacity (K Pcs) of Major Manufacturers (2014-2019)
Table Celiac Disease Drug Production (K Pcs) of Major Manufacturers (2014-2019)
Table Celiac Disease Drug Production Market Share of Major Manufacturers (2014-2019)
Figure Celiac Disease Drug Production Share by Manufacturers in 2018
Table Celiac Disease Drug Revenue (Million US$) of Major Manufacturers (2014-2019)
Table Celiac Disease Drug Revenue Market Share of Major Manufacturers (2014-2019)
Figure Celiac Disease Drug Revenue Share by Manufacturers in 2018
Table Celiac Disease Drug Average Price (USD/Pcs) of Major Manufacturers (2014-2019)
Table Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Global Celiac Disease Drug Production by Regions 2014-2019 (K Pcs)
Table Global Celiac Disease Drug Production Market Share by Regions 2014-2019
Figure Global Celiac Disease Drug Production Market Share by Regions in 2018
Table Global Celiac Disease Drug Revenue by Regions 2014-2019 (Million USD)
Table Global Celiac Disease Drug Revenue Market Share by Regions 2014-2019
Figure Global Celiac Disease Drug Revenue Market Share by Regions in 2018
Table Global Celiac Disease Drug Consumption by Regions 2014-2019 (K Pcs)
Table Global Celiac Disease Drug Consumption Market Share by Regions 2014-2019
Figure North America Celiac Disease Drug Production Growth Rate 2014-2019 (K Pcs)
Figure North America Celiac Disease Drug Revenue Growth Rate 2014-2019 (Million USD)
Table North America Celiac Disease Drug Production, Consumption Import and Export (K Pcs)
Figure Europe Celiac Disease Drug Production Growth Rate 2014-2019 (K Pcs)
Figure Europe Celiac Disease Drug Revenue Growth Rate 2014-2019 (Million USD)
Table Europe Celiac Disease Drug Production, Consumption Import and Export (K Pcs)
Figure China Celiac Disease Drug Production Growth Rate 2014-2019 (K Pcs)
Figure China Celiac Disease Drug Revenue Growth Rate 2014-2019 (Million USD)
Table China Celiac Disease Drug Production, Consumption Import and Export (K Pcs)
Figure Japan Celiac Disease Drug Production Growth Rate 2014-2019 (K Pcs)
Figure Japan Celiac Disease Drug Revenue Growth Rate 2014-2019 (Million USD)
Table Japan Celiac Disease Drug Production, Consumption Import and Export (K Pcs)
Figure Southeast Asia Celiac Disease Drug Production Growth Rate 2014-2019 (K Pcs)
Figure Southeast Asia Celiac Disease Drug Revenue Growth Rate 2014-2019 (Million USD)
Table Southeast Asia Celiac Disease Drug Production, Consumption Import and Export (K Pcs)
Figure India Celiac Disease Drug Production Growth Rate 2014-2019 (K Pcs)
Figure India Celiac Disease Drug Revenue Growth Rate 2014-2019 (Million USD)
Table India Celiac Disease Drug Production, Consumption Import and Export (K Pcs)
Figure Global Consumption Celiac Disease Drug Market Share by Application (2014-2019)
Figure Global Value (Consumption) Celiac Disease Drug Market Share by Application (2014-2019)
Table F. Hoffmann-La Roche Celiac Disease Drug Production Sites and Area Served
Table F. Hoffmann-La Roche Celiac Disease Drug Product Introduction, Application and Specification
Table F. Hoffmann-La Roche Celiac Disease Drug Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table F. Hoffmann-La Roche Celiac Disease Drug Production Growth Rate (2014-2019)
Table F. Hoffmann-La Roche Celiac Disease Drug Production Market Share (2014-2019)
Figure F. Hoffmann-La Roche Celiac Disease Drug Revenue Market Share (2014-2019)
Table F. Hoffmann-La Roche Celiac Disease Drug Main Business and Markets Served
Table Johnson & Johnson Celiac Disease Drug Production Sites and Area Served
Table Johnson & Johnson Celiac Disease Drug Product Introduction, Application and Specification
Table Johnson & Johnson Celiac Disease Drug Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Johnson & Johnson Celiac Disease Drug Production Growth Rate (2014-2019)
Table Johnson & Johnson Celiac Disease Drug Production Market Share (2014-2019)
Figure Johnson & Johnson Celiac Disease Drug Revenue Market Share (2014-2019)
Table Johnson & Johnson Celiac Disease Drug Main Business and Markets Served
Table Merck Celiac Disease Drug Production Sites and Area Served
Table Merck Celiac Disease Drug Product Introduction, Application and Specification
Table Merck Celiac Disease Drug Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Merck Celiac Disease Drug Production Growth Rate (2014-2019)
Table Merck Celiac Disease Drug Production Market Share (2014-2019)
Figure Merck Celiac Disease Drug Revenue Market Share (2014-2019)
Table Merck Celiac Disease Drug Main Business and Markets Served
Table Pfizer Celiac Disease Drug Production Sites and Area Served
Table Pfizer Celiac Disease Drug Product Introduction, Application and Specification
Table Pfizer Celiac Disease Drug Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Pfizer Celiac Disease Drug Production Growth Rate (2014-2019)
Table Pfizer Celiac Disease Drug Production Market Share (2014-2019)
Figure Pfizer Celiac Disease Drug Revenue Market Share (2014-2019)
Table Pfizer Celiac Disease Drug Main Business and Markets Served
Table ADMA Biologics Celiac Disease Drug Production Sites and Area Served
Table ADMA Biologics Celiac Disease Drug Product Introduction, Application and Specification
Table ADMA Biologics Celiac Disease Drug Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table ADMA Biologics Celiac Disease Drug Production Growth Rate (2014-2019)
Table ADMA Biologics Celiac Disease Drug Production Market Share (2014-2019)
Figure ADMA Biologics Celiac Disease Drug Revenue Market Share (2014-2019)
Table ADMA Biologics Celiac Disease Drug Main Business and Markets Served
Table Amgen Celiac Disease Drug Production Sites and Area Served
Table Amgen Celiac Disease Drug Product Introduction, Application and Specification
Table Amgen Celiac Disease Drug Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Amgen Celiac Disease Drug Production Growth Rate (2014-2019)
Table Amgen Celiac Disease Drug Production Market Share (2014-2019)
Figure Amgen Celiac Disease Drug Revenue Market Share (2014-2019)
Table Amgen Celiac Disease Drug Main Business and Markets Served
Table Anthera Pharmaceuticals Celiac Disease Drug Production Sites and Area Served
Table Anthera Pharmaceuticals Celiac Disease Drug Product Introduction, Application and Specification
Table Anthera Pharmaceuticals Celiac Disease Drug Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Anthera Pharmaceuticals Celiac Disease Drug Production Growth Rate (2014-2019)
Table Anthera Pharmaceuticals Celiac Disease Drug Production Market Share (2014-2019)
Figure Anthera Pharmaceuticals Celiac Disease Drug Revenue Market Share (2014-2019)
Table Anthera Pharmaceuticals Celiac Disease Drug Main Business and Markets Served
Table Bayer Celiac Disease Drug Production Sites and Area Served
Table Bayer Celiac Disease Drug Product Introduction, Application and Specification
Table Bayer Celiac Disease Drug Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Bayer Celiac Disease Drug Production Growth Rate (2014-2019)
Table Bayer Celiac Disease Drug Production Market Share (2014-2019)
Figure Bayer Celiac Disease Drug Revenue Market Share (2014-2019)
Table Bayer Celiac Disease Drug Main Business and Markets Served
Table Biogen Celiac Disease Drug Production Sites and Area Served
Table Biogen Celiac Disease Drug Product Introduction, Application and Specification
Table Biogen Celiac Disease Drug Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Biogen Celiac Disease Drug Production Growth Rate (2014-2019)
Table Biogen Celiac Disease Drug Production Market Share (2014-2019)
Figure Biogen Celiac Disease Drug Revenue Market Share (2014-2019)
Table Biogen Celiac Disease Drug Main Business and Markets Served
Table BioLineRx Celiac Disease Drug Production Sites and Area Served
Table BioLineRx Celiac Disease Drug Product Introduction, Application and Specification
Table BioLineRx Celiac Disease Drug Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table BioLineRx Celiac Disease Drug Production Growth Rate (2014-2019)
Table BioLineRx Celiac Disease Drug Production Market Share (2014-2019)
Figure BioLineRx Celiac Disease Drug Revenue Market Share (2014-2019)
Table BioLineRx Celiac Disease Drug Main Business and Markets Served
Table Biotest Celiac Disease Drug Production Sites and Area Served
Table Bristol-Myers Squibb Celiac Disease Drug Production Sites and Area Served
Table Celgene Celiac Disease Drug Production Sites and Area Served
Table Takeda Pharmaceutical Celiac Disease Drug Production Sites and Area Served
Table Novartis Celiac Disease Drug Production Sites and Area Served
Table LFB Group Celiac Disease Drug Production Sites and Area Served
Table Kedrion Biopharma Celiac Disease Drug Production Sites and Area Served
Figure Global Celiac Disease Drug Production (K Pcs) Growth Rate Forecast 2019-2025
Figure Global Celiac Disease Drug Revenue (Million USD) Growth Rate Forecast 2019-2025
Figure Global Celiac Disease Drug Sales Price (USD/Pcs) Forecast 2019-2025
Figure North America Celiac Disease Drug Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure North America Celiac Disease Drug Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Europe Celiac Disease Drug Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure Europe Celiac Disease Drug Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure China Celiac Disease Drug Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure China Celiac Disease Drug Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Japan Celiac Disease Drug Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure Japan Celiac Disease Drug Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Southeast Asia Celiac Disease Drug Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure Southeast Asia Celiac Disease Drug Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure India Celiac Disease Drug Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure India Celiac Disease Drug Revenue Growth Rate Forecast 2019-2025 (Million USD)
Table Global Production (K Pcs) of Celiac Disease Drug by Type (2019-2025)
Table Global Consumption (K Pcs) of Celiac Disease Drug by Application (2019-2025)
Table Celiac Disease Drug Distributors List
Table Celiac Disease Drug Customers List
Table Market Key Trends
Table Key Opportunities
Table Market Key Drivers
Table Key Challenges
Table Key Influence Factors
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
Request Discount 
Inquire Before Buy
